Breast Cancer

Melanie A. Nix, co-founder of the Breast Cancer Comfort Site, provides advices for a new cancer advocate.

Sue Friedman, discusses the ABOUT Network, which is the first-ever patient-powered research registry created and governed by and for people affected by hereditary breast and ovarian cancers.

If you meet a patient who is pregnant with a breast cancer diagnosis, a nurse navigator is invaluable, and there are many important considerations.

Mary B. Daly, MD, PhD, from Fox Chase Cancer Center, discusses the proper timing for screening patients with a family history of cancer.

Kara Maxwell, MD, PhD, instructor, medical oncologist, Basser Research Center for BRCA, University of Pennsylvania, discusses the need to personalize the treatment of breast cancer.

A study looking at the care experiences and possible stressors for Latina women undergoing chemotherapy to treat their breast cancer has found that this patient population feels particular stress related to their family and other interpersonal relationships.

The number of women deciding to have breast-conserving therapy to treat their early-stage breast cancer has been steadily increasing, but these gains are muted for some women due to such factors as insurance status, income, and travel distance to treatment centers.

Adding palbociclib (Ibrance) to standard fulvestrant more than doubled progression-free survival in pretreated patients with HR-positive, HER2-negative breast cancer, according to study results presented at the 2015 ASCO Annual Meeting.

Weight training was shown to help stave off deterioration of physical function in breast cancer survivors, conferring a benefit twice that of women in a control group who did not participate in the weight-lifting intervention.

Imagine a woman with a weight problem who, two weeks after chemotherapy, goes to her doctor with a urinary tract infection and a rash on her upper chest.

Breast density, which is associated with breast cancer risk, is higher in black/African-American women than in white women, according to research presented at the AACR Annual Meeting.

The PD-L1 inhibitor MPDL3280A demonstrated a 19% objective response rate (ORR) with 75% of responses ongoing in pretreated patients with metastatic triple-negative breast cancer (TNBC), according to findings from an ongoing phase I study presented at the 2015 AACR Annual Meeting.

New research reported at the AACR Annual Meeting has found that decreasing the number of hours spent eating each day and increasing the number of hours spent fasting overnight may reduce a woman's risk of developing breast cancer.

A new telephone-based intervention for breast cancer survivors is showing promise, and it involves them becoming more actively engaged in goal setting and problem solving with an eye toward accelerating their recovery by engaging in health-promoting activities such as exercise, stress management, and healthy eating.

Many women who are diagnosed with breast cancer are concerned about the genetic risk of developing other cancers themselves or of a loved one developing cancer. However, a large amount of those concerns are not being addressed, according to a new study.

Angelina Jolie Pitt recently added another chapter to her BRCA mutation story, making public her choice to undergo a preventive salpingo-oophorectomy, removal of her ovaries and fallopian tubes to reduce her risk of cancer.

The link between diabetes and late-stage breast cancer is strong, according to a new study.

Clifford A. Hudis, MD, chief, Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, professor of medicine, Weill Cornell Medical College, discusses the challenges of understanding the link between obesity and cancer.

Pierre Adams shares her story on being diagnosed while being pregnant with twins

In 2009, Connecticut became the first state to enact legislation mandating that patients undergoing mammography be informed of their breast density and the option to have a follow-up ultrasound.

Results of a follow up study have shown that when women were taught stress management techniques early in their breast cancer treatment, their mood and quality of life continued to improve up to 15 years later.

In this roundtable, representatives from Sharsheret, the Cancer Support Community, the Young Survival Coalition, and Living Beyond Breast Cancer discuss the impact of metastatic breast cancer.

A new study has found that African American patients with cancer feel and describe depression differently than their Caucasian counterparts.

Deanna J. Attai, MD, breast surgeon, assistant clinical professor of surgery, David Geffen School of Medicine, University of California, Los Angeles, gives advice to nurses on how to manage pain in breast cancer patients.

A new study hopes to gain some clarity on what causes some breast cancer patients to feel "foggy" when receiving chemotherapy.

According to a recent retrospective cohort analysis of a large national database, patients with a history of breast cancer have a higher risk of developing thyroid cancer than do the general population, particularly if they receive adjuvant radiation therapy.

Having a family history of prostate cancer among first-degree relatives may also increase a women's risk of developing breast cancer, according to a new study.

Clifford A. Hudis, MD, chief, Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, professor of medicine, Weill Cornell Medical College, discusses the link between obesity and cancer.

Hyman B. Muss, MD, professor of oncology, University of North Carolina, director, Geriatric Oncology, Lineberger Comprehensive Cancer Center, discusses tamoxifen as breast cancer prevention

With a career as remarkable and distinguished as Joan Lunden's, it's really no surprise that she took on her latest challenge-a diagnosis of triple-negative breast cancer-with such determination and grace.